Meeting
2022 ASCO Annual Meeting
HER2 in uterine carcinosarcoma: Testing platforms and implications for targeted therapy.
Authors
Navin Maredia
University of Minnesota, Minneapolis, MN
Navin Maredia , Sharon Wu , Alex Farrell , Matthew James Oberley , Lauren Thomaier , Nathaniel L. Jones , Thomas J. Herzog , Premal H. Thaker , Matthew A. Powell , Tenley Klc , Britt Kristina Erickson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 5590)
DOI
10.1200/JCO.2022.40.16_suppl.5590
Abstract #
5590
Poster Bd #
466
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
HER2 in uterine serous carcinoma: Testing platforms and implications for targeted therapy.
First Author: Tenley Klc
Poster
2016 Genitourinary Cancers Symposium
Molecular profiling of non-urothelial bladder cancer: Adenocarcinoma and squamous cell carcinoma.
First Author: Daniel M. Geynisman
First Author: Jue Wang
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff